Logo
x

Search

Subscribe Now

CHMP

Fresenius Kabi and Formycon Report the CHMP’s Positive Opinion of FYB202 (Biosimilar, Stelara)

Fresenius Kabi and Formycon Report the CHMP’s Positive Opinion of FYB202 (Biosimilar, Stelara)

  • July 29, 2024
Astellas Reports the CHMP’s Positive Opinion of Zolbetuximab to Treat Gastric and Gastroesophageal Junction Cancer

Astellas Reports the CHMP’s Positive Opinion of Zolbetuximab to Treat Gastric and Gastroesophageal Junction Cancer

  • July 29, 2024
Insights+: EMA Marketing Authorization of New Drugs in February 2024

Insights+: EMA Marketing Authorization of New Drugs in February 2024

  • March 20, 2024
Calliditas Receives CHMP Positive Opinion of Kinpeygo for the Treatment of Primary Immunoglobulin A Nephropathy

Calliditas Receives CHMP Positive Opinion of Kinpeygo for the Treatment of Primary Immunoglobulin A Nephropathy

  • May 20, 2022
Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung...

  • November 15, 2021
Vertex's Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Receives CHMP's Positive Opinion for the Treatment of Cystic Fibrosis in Children Aged 6 to 11

Vertex's Kaftrio (ivacaftor/tezacaftor/elexacaftor) + Ivacaftor Receives CHMP's Positive Opinion for the Treatment of Cystic Fibro...

  • November 15, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.